Prenatal diagnosis and genetic analysis of a fetus with Cornelia de Lange syndrome type 1 due to a splicing variant of NIPBL gene.
10.3760/cma.j.cn511374-20210916-00753
- Author:
Lei LIANG
1
;
Haixin WANG
;
Zeyu CAI
;
Jianrong ZHAO
Author Information
1. Prenatal Diagnosis Center, the Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Nei Monggol 010050, China. 45976953@qq.com.
- Publication Type:Journal Article
- MeSH:
Cell Cycle Proteins/genetics*;
De Lange Syndrome/genetics*;
Female;
Fetus;
Humans;
Mutation;
Pregnancy;
Prenatal Diagnosis;
RNA, Messenger
- From:
Chinese Journal of Medical Genetics
2022;39(10):1107-1110
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the genetic etiology of a fetus with Cornelia de Lange syndrome type 1.
METHODS:Clinical data of the fetus was collected. Genomic DNA was extracted from amniotic fluid and peripheral blood samples of the parents and subjected to low-depth copy number variant sequencing, whole exome sequencing (WES) and Sanger sequencing. Pathogenicity of the candidate variant was predicted based on the guidelines of American College of Medical Genetics and Genomics (ACMG). Minigene assay was used to assess the effect of the variant on mRNA splicing.
RESULTS:WES revealed that the fetus has harbored a heterozygous c.5808+5gG>A variant in the intron of the NIPBL gene, which was predicted to affect the mRNA splicing. The same variant was not detected in either parent. The variant was not recorded in ExAC, 1000G and dbSNP databases. Comprehensive analysis showed that the variant was deleterious and may result in skipping of exon 31 during mRNA splicing.
CONCLUSION:The fetus was diagnosed with Cornelia de Lange syndrome type 1. Splicing variant identified by WES may be verified by minigene assay in vitro, which can provide more evidence for the prediction of its pathogenicity.
